17:03 EDT Biodexa Pharmaceuticals (BDRX) files $100M mixed securities shelf
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Biodexa Pharmaceuticals Advances Serenta Trial and Secures Financial Backing
- Biodexa says requirement for financing represents ‘material uncertainty’
- Biodexa Pharmaceuticals reports 1H EPS (GBP0.0002) vs. (GBP0.001) last year
- Biodexa Pharmaceuticals Begins Phase 3 Trial for FAP Treatment
- Biodexa announces enrollment of first two patients in Phase 3 Serenta trial